CSIMarket
 


Watson Pharmaceuticals Inc  (WPI)
Other Ticker:  
 
    Sector  Consumer Non Cyclical    Industry Legacy
   Industry Legacy
   Sector  Consumer Non Cyclical
 

WPI's Revenue Growth by Quarter and Year

Watson Pharmaceuticals Inc's Revenue results by quarter and year




WPI Revenue (in millions $) FY 2012 FY 2011 FY 2010 FY 2009
IV Quarter December - 1,544.60 952.70 785.70
III Quarter September 1,285.20 1,081.60 882.40 662.10
II Quarter June 1,355.20 1,081.70 875.30 677.80
I Quarter March 1,524.30 876.50 856.50 667.40
FY   4,164.70 4,584.40 3,566.90 2,793.00



WPI Revenue third quarter 2012 Y/Y Growth Comment
Watson Pharmaceuticals Inc achieved in the third quarter, above Company average Revenue increase of 18.82% year on year, to $ 1,285.20 millions.

According to the results reported in the third quarter, Watson Pharmaceuticals Inc achieved the best Revenue growth in Legacy industry. While Watson Pharmaceuticals Inc' s Revenue growth of 18.82% ranks overall at the positon no. 70 in the third quarter.




WPI Revenue ( Y/Y Growth %) 2012
2011 2010 2009
IV Quarter December - 62.13 % 21.25 % 21.77 %
III Quarter September 18.82 % 22.57 % 33.27 % 3.34 %
II Quarter June 25.28 % 23.58 % 29.14 % 8.86 %
I Quarter March 73.91 % 2.34 % 28.33 % 6.45 %
FY   - 28.53 % 27.71 % 10.16 %

Financial Statements
Watson Pharmaceuticals Inc's third quarter 2012 Revenue $ 1,285.20 millions WPI's Income Statement
Watson Pharmaceuticals Inc's third quarter 2011 Revenue $ 1,081.60 millions Quarterly WPI's Income Statement
New: More WPI's historic Revenue Growth >>


WPI Revenue (Quarter on Quarter Growth %)

2012
2011 2010 2009
IV Quarter December - 42.81 % 7.97 % 18.67 %
III Quarter September -5.17 % -0.01 % 0.81 % -2.32 %
II Quarter June -11.09 % 23.41 % 2.19 % 1.56 %
I Quarter March -1.31 % -8 % 9.01 % 3.44 %
FY (Year on Year)   - 28.53 % 27.71 % 10.16 %




Revenue third quarter 2012 Y/Y Growth Company Ranking
Within: No.
Legacy Industry #1
Consumer Non Cyclical Sector #4
Overall #70

Revenue Y/Y Growth Statistics
High Average Low
73.91 % 18.53 % -6.65 %
(March 31, 2012)   (March 31, 2008)
Revenue third quarter 2012 Y/Y Growth Company Ranking
Within: No.
Legacy Industry #1
Consumer Non Cyclical Sector #4
Overall #70
Revenue Y/Y Growth Statistics
High Average Low
73.91 % 18.53 % -6.65 %
(March 31, 2012)   (March 31, 2008)

Revenue by Quarter for the Fiscal Years 2009, 2010, 2011, 2012

Watson Pharmaceuticals Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
42.81 % 4.01 % -13.69 %
(Dec. 30. 2011)  


WPI's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2012 Watson Pharmaceuticals Inc disclosed decline in Revenue from the second quarter by -5.17% to $ 1,285.20 millions, from $ 1,355.20 millions achived in the previous reporting period.

When you analyse present downturn in the quarter, you should assume, that commonly III. Quarter Revenue emerge sluggish relative to the quarter before, Grazia Esposito, an industry contributor from Zurich mentioned.

Within Legacy industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Watson Pharmaceuticals Inc's Revenue growth quarter on quarter, overall rank is 2574.


Revenue Q/Q Growth Company Ranking
Within: No.
Legacy Industry #7
Consumer Non Cyclical Sector #99
Overall #2574
Revenue Q/Q Growth Company Ranking
Within: No.
Legacy Industry #7
Consumer Non Cyclical Sector #99
Overall #2574
Revenue Q/Q Growth Statistics
High Average Low
42.81 % 4.01 % -13.69 %
(Dec. 30. 2011)  


WPI's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2012 Watson Pharmaceuticals Inc disclosed decline in Revenue sequentially by -5.17% to $ 1,285.20 millions, from $ 1,355.20 millions achived in the previous quarter.

It's not big concern, as III. Quarter Revenue generally tend to dip in the III. Quarter Grazia Esposito, an industry contributor from Zurich told.

Within Legacy industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Watson Pharmaceuticals Inc's Revenue growth quarter on quarter, overall rank is 2574.


Watson Pharmaceuticals Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep. 30, 2012)
12 Months Ending
(June 30. 2012)
12 Months Ending
(March 31, 2012)
12 Months Ending
(Dec. 30. 2011)
12 Months Ending
(Sep. 30, 2011)
Cumulative Revenue 12 Months Ending $ 5,709.30 $ 5,505.70 $ 5,232.20 $ 4,584.40 $ 3,992.50
Y / Y Revenue Growth (TTM) 43 % 45.14 % 45.87 % 28.53 % 17.43 %
Year on Year Revenue Growth Overall Ranking # 24 # 29 # 0 # 0 # 28
Seqeuential Revenue Change (TTM) 3.7 % 5.23 % 14.13 % 14.83 % 5.25 %
Seq. Revenue Growth (TTM) Overall Ranking # 72 # 202 # 0 # 0 # 79




Cumulative Revenue growth Comment
Assuming the Watson Pharmaceuticals Inc's fiscal year would have ended in Sep. 30, 2012, Watson Pharmaceuticals Inc would have reprted above average annual Revenue growth of 43% year on year, of $ 5,709 millions.
This marks a slow-down of the companys growth trends and from the 45.14% increase in June 30. 2012. But still, Watson Pharmaceuticals Inc had highest Revenue growth, in Legacy industry.

Looking into Consumer Non Cyclical sector trailing twelve month Revenue increase, only one company had higher growth. While Total ranking has impoved so far to 24, from total ranking in previous quarter at 29.

Revenue TTM Q/Q Growth Statistics
High Average Low
14.83 %
4.47 %
-1.79 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legacy Industry # 1
Consumer Non Cyclical Sector # 2
Overall # 24

Revenue TTM Y/Y Growth Statistics
High Average Low
45.87 %
18.27 %
0.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 3
S&P 500 # 72
Cumulative Revenue growth Comment
Assuming the Watson Pharmaceuticals Inc's fiscal year would have ended in Sep. 30, 2012, Watson Pharmaceuticals Inc would have reprted above average annual Revenue growth of 43% year on year, of $ 5,709 millions.
This marks a slow-down of the companys growth trends and from the 45.14% increase in June 30. 2012. But still, Watson Pharmaceuticals Inc had highest Revenue growth, in Legacy industry.

Looking into Consumer Non Cyclical sector trailing twelve month Revenue increase, only one company had higher growth. While Total ranking has impoved so far to 24, from total ranking in previous quarter at 29.

Revenue TTM Q/Q Growth Statistics
High Average Low
14.83 %
4.47 %
-1.79 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legacy Industry # 1
Consumer Non Cyclical Sector # 2
Overall # 24

Revenue TTM Y/Y Growth Statistics
High Average Low
45.87 %
18.27 %
0.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 3
S&P 500 # 72




Other Revenue Growth
Legacy Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
WPI's Revenue Growth Ratio versus Legacy Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for WPI's Competitors
Revenue Growth for Watson Pharmaceuticals Inc's Suppliers
Revenue Growth for WPI's Customers

You may also want to know
WPI's Annual Growth Rates WPI's Profitability Ratios WPI's Asset Turnover Ratio WPI's Dividend Growth
WPI's Roe WPI's Valuation Ratios WPI's Financial Strength Ratios WPI's Dividend Payout Ratio
WPI's Roa WPI's Inventory Turnover Ratio WPI's Growth Rates WPI's Dividend Comparisons



Companies with similar Revenue increase for the quarter ending Sep 30 2012 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Sep 30 2012
Molson Coors Beverage Company25.26%$ 25.262 millions
Watson Pharmaceuticals Inc18.82%$ 18.824 millions
Kellogg Company12.32%$ 12.319 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HMTV's Profile

Stock Price

HMTV's Financials

Business Description

Fundamentals

Charts & Quotes

HMTV's News

Suppliers

HMTV's Competitors

Customers & Markets

Economic Indicators

HMTV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071